AK106-001616, a Potent and Selective Inhibitor of Cytosolic Phospholipase A2: In Vivo Efficacy for Inflammation, Neuropathic Pain, and Pulmonary Fibrosis.
J Pharmacol Exp Ther
; 369(3): 511-522, 2019 06.
Article
in En
| MEDLINE
| ID: mdl-30971478
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Propionates
/
Pulmonary Fibrosis
/
Anti-Inflammatory Agents, Non-Steroidal
/
Enzyme Inhibitors
/
Group IV Phospholipases A2
/
Indans
/
Indazoles
/
Neuralgia
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2019
Type:
Article
Affiliation country:
Japan